Vereshchagin E.I., Svechnikova E.V., Maksimova Yu.V., Arutyunyan G.B., Artemyeva N.O., Devyatova A.V.
Hyperuricemia as a marker of chronic systemic inflammation in the pathogenesis of psoriasis
|
№5 / 2024
|
N.O. Pereverzina, L.S. Kruglova, T.V. Korotaeva, A.M. Lila
Systematic review and meta-analysis: predictors of psoriatic arthritis
|
№14 / 2022
|
L.S. Kruglova, N.O. Pereverzina
The effectiveness of early administration of interleukin-17 blockers in the treatment of axial lesions in psoriatic arthritis
|
№14 / 2021
|
N.A. Merzlikina (1), E.V. Svechnikova (1, 2), S.E. Zhufina (1)
Modern therapy of psoriasis from the point of view of systemic inflammation: experience of using the drug Efleira
|
№8 / 2021
|
O.G. Filimonova, O.V. Simonova
DYNAMICS OF PSYCHOEMOTICAL STATUS IN PATIENTS WITH PSORIATIC ARTHRITIS AGAINST THE BACKGROUND OF DISEASE-MODIFYING THERAPY
|
№s3-17 / 2017
|
O.G. Filimonova, O.V. Simonova
FEATURES QUALITY OF LIFE AND VEGETATIVE STATUS IN PATIENTS WITH PSORIATIC ARTHRITIS AND ANXIETY-DEPRESSIVE DISORDERS
|
№7 / 2016
|
M.I. Kurdina
MONOCLONAL ANTIBODIES IN THE TREATMENT OF PSORIASIS AND PSORIATIC ARTHRITIS
|
№7 / 2016
|
T.V. Korotaeva
ADVANCES IN THE TREATMENT OF PSORIATIC ARTHRITIS
|
№7 / 2015
|
I.Yu. Zinchuk
PHARMACOECONOMIC ANALYSIS OF GENETICALLY ENGINEERED BIOLOGICAL PRODUCTS USED IN THE TREATMENT OF PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS
|
№7 / 2014
|
T.V. Korotaeva
CURRENT TREATMENT OF PSORIATIC ARTHRITIS
|
№20 / 2013
|
V.V. Badokin
Efficacy And Tolerability Of Methotrexate In Psoriatic Arthritis
|
№19 / 2012
|